| Bone Diseases |
NCT03029442: The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury |
|
|
| Terminated | 4 | 5 | US | Denosumab (Prolia), Xgeva, Placebo (normal saline) | James J. Peters Veterans Affairs Medical Center, Kessler Institute for Rehabilitation | Secondary Osteoporosis, Spinal Cord Injury | 12/21 | 10/22 | | |
NCT00359047: Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme |
|
|
| Active, not recruiting | N/A | 2830 | Canada | Documentation, Video | CHU de Quebec-Universite Laval, Merck Frosst Canada Ltd., Sanofi, Procter and Gamble, Amgen, Eli Lilly and Company, Novartis | Osteoporosis | 10/07 | 12/25 | | |
NCT00493532: A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. |
|
|
| No Longer Available | N/A | | RoW | ibandronate [Bonviva/Boniva] | Hoffmann-La Roche | Postmenopausal Osteoporosis | 12/10 | 12/10 | | |
| No Longer Available | N/A | | RoW | Technetium labelled glucosamine | University of Sydney, AbbVie | Rheumatoid Arthritis, Ankylosing Spondylitis | | | | |
NCT02557308: An Observational Study to Evaluate Safety and Efficacy of Remsimaâ„¢ in Patients With Ankylosing Spondylitis |
|
|
| Recruiting | N/A | 1000 | RoW | | Celltrion | Ankylosing Spondylitis | 06/20 | 06/26 | | |